Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.5 USD | -1.10% | +17.80% | -25.00% |
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.82 for the current period. Therefore, the company is undervalued.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last few months, analysts have been revising downwards their earnings forecast.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-25.00% | 619M | C- | ||
+16.49% | 83.4B | C+ | ||
-29.52% | 72.11B | B- | ||
0.00% | 27.04B | C+ | ||
-13.29% | 16.96B | B | ||
+1.03% | 16.86B | A- | ||
+1.57% | 15.76B | A- | ||
+71.63% | 13.33B | C- | ||
+1.53% | 12.76B | B- | ||
+70.68% | 12.74B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- INNV Stock
- Ratings InnovAge Holding Corp.